Rare diseases
Investigational molecules
Locations
10275 Science Center Drive Suite 200, 92121-1170, United States
Research activity includes high-grade serous ovarian cancer, platinum-resistant ovarian cancer, and primary peritoneal cancer, with attention to treatment-resistant disease and antitumor activity in women with advanced gynecologic cancers.
These programs focus on recurrent and persistent disease settings where new therapeutic options are needed.
K-Group Beta Inc. runs clinical trials in conditions such as Malignant peritoneal neoplasm, Fallopian tube cancer, Ovarian cancer, Ovarian cancer recurrent, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgium
FranceFrance
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
